1. Home
  2. GFAI vs SPRC Comparison

GFAI vs SPRC Comparison

Compare GFAI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • SPRC
  • Stock Information
  • Founded
  • GFAI 2018
  • SPRC 2004
  • Country
  • GFAI Singapore
  • SPRC Israel
  • Employees
  • GFAI N/A
  • SPRC N/A
  • Industry
  • GFAI Diversified Commercial Services
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • SPRC Health Care
  • Exchange
  • GFAI Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • GFAI N/A
  • SPRC 2.3M
  • IPO Year
  • GFAI N/A
  • SPRC N/A
  • Fundamental
  • Price
  • GFAI $1.18
  • SPRC $0.22
  • Analyst Decision
  • GFAI Strong Buy
  • SPRC
  • Analyst Count
  • GFAI 3
  • SPRC 0
  • Target Price
  • GFAI $9.17
  • SPRC N/A
  • AVG Volume (30 Days)
  • GFAI 237.9K
  • SPRC 1.6M
  • Earning Date
  • GFAI 10-25-2024
  • SPRC 11-28-2024
  • Dividend Yield
  • GFAI N/A
  • SPRC N/A
  • EPS Growth
  • GFAI N/A
  • SPRC N/A
  • EPS
  • GFAI N/A
  • SPRC N/A
  • Revenue
  • GFAI $35,841,743.00
  • SPRC $2,879,000.00
  • Revenue This Year
  • GFAI N/A
  • SPRC N/A
  • Revenue Next Year
  • GFAI N/A
  • SPRC N/A
  • P/E Ratio
  • GFAI N/A
  • SPRC N/A
  • Revenue Growth
  • GFAI 1.78
  • SPRC 113.73
  • 52 Week Low
  • GFAI $1.03
  • SPRC $0.21
  • 52 Week High
  • GFAI $4.37
  • SPRC $14.22
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 45.50
  • SPRC 33.14
  • Support Level
  • GFAI $1.11
  • SPRC $0.21
  • Resistance Level
  • GFAI $1.19
  • SPRC $0.23
  • Average True Range (ATR)
  • GFAI 0.07
  • SPRC 0.01
  • MACD
  • GFAI 0.01
  • SPRC 0.00
  • Stochastic Oscillator
  • GFAI 47.62
  • SPRC 28.67

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: